Literature DB >> 1684519

Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.

B Lavoie1, A Parent.   

Abstract

In cynomolgus monkeys, midbrain neurons immunoreactive (IR) for the calcium-binding protein calbindin D-28k (CaBP) occur principally in the dorsal tier of substantia nigra pars compacta (SNc) and in the ventral tegmental area (VTA), and most of these neurons co-express tyrosine hydroxylase (TH). In monkeys rendered parkinsonian (PD) after MPTP injections, CaBP-IR neurons are much less severely affected than TH-IR neurons in SNc and in VTA, and most spared neurons in SNc/VTA display both CaBP and TH immunoreactivity. These results reveal that, in contrast to the situation in other neurodegenerative diseases, CaBP may be used as a marker for a specific neuronal population that is less prone to degeneration in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684519     DOI: 10.1097/00001756-199110000-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  32 in total

1.  Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum.

Authors:  S N Haber; J L Fudge; N R McFarland
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.

Authors:  Angela Cruz-Hernandez; Zeynep Sena Agim; Paola C Montenegro; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Neurotoxicology       Date:  2018-03       Impact factor: 4.294

Review 3.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study.

Authors:  M Paquet; M Tremblay; J J Soghomonian; Y Smith
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

5.  In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.

Authors:  LinLin Tian; Morvarid Karimi; Chris A Brown; Susan K Loftin; Joel S Perlmutter
Journal:  Brain Res       Date:  2014-05-15       Impact factor: 3.252

6.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

7.  Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants.

Authors:  S A Bayer; K V Wills; L C Triarhou; J D Thomas; B Ghetti
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

8.  Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice.

Authors:  S A Bayer; K V Wills; L C Triarhou; T Verina; J D Thomas; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 9.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

Review 10.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.